Suivre
KEIICHI OHATA
KEIICHI OHATA
St. Marianna University School of Medicine
Adresse e-mail validée de marianna-u.ac.jp
Titre
Citée par
Citée par
Année
DNA released from dying host cells mediates aluminum adjuvant activity
T Marichal, K Ohata, D Bedoret, C Mesnil, C Sabatel, K Kobiyama, ...
Nature medicine 17 (8), 996-1002, 2011
6142011
Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms
E Kuroda, KJ Ishii, S Uematsu, K Ohata, C Coban, S Akira, K Aritake, ...
Immunity 34 (4), 514-526, 2011
2302011
Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9
C Coban, Y Igari, M Yagi, T Reimer, S Koyama, T Aoshi, K Ohata, ...
Cell host & microbe 7 (1), 50-61, 2010
2202010
TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN
B Temizoz, E Kuroda, K Ohata, N Jounai, K Ozasa, K Kobiyama, T Aoshi, ...
European journal of immunology 45 (4), 1159-1169, 2015
1342015
Inhaled fine particles induce alveolar macrophage death and interleukin-1α release to promote inducible bronchus-associated lymphoid tissue formation
E Kuroda, K Ozasa, B Temizoz, K Ohata, CX Koo, T Kanuma, T Kusakabe, ...
Immunity 45 (6), 1299-1310, 2016
1242016
Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen
M Onishi, K Ozasa, K Kobiyama, K Ohata, M Kitano, K Taniguchi, ...
The Journal of Immunology 194 (6), 2673-2682, 2015
712015
Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism
H Zhao, A Konishi, Y Fujita, M Yagi, K Ohata, T Aoshi, S Itagaki, S Sato, ...
Cell host & microbe 12 (5), 705-716, 2012
652012
The malarial metabolite hemozoin and its potential use as a vaccine adjuvant
C Coban, M Yagi, K Ohata, Y Igari, T Tsukui, T Horii, KJ Ishii, S Akira
Allergology International 59 (2), 115-124, 2010
622010
The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant
CK Tang, T Aoshi, N Jounai, J Ito, K Ohata, K Kobiyama, BH Dessailly, ...
PloS one 8 (3), e60038, 2013
402013
Serum Liver‐Type Fatty Acid–Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma
A Eguchi, H Hasegawa, M Iwasa, Y Tamai, K Ohata, T Oikawa, T Sugaya, ...
Hepatology Communications 3 (6), 825-837, 2019
232019
Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia–reperfusion
D Ichikawa, A Kamijo‐Ikemori, T Sugaya, K Ohata, M Hisamichi, ...
Nephrology 23 (4), 308-316, 2018
212018
Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats
S Yamada, J Tanabe, Y Ogura, Y Nagai, T Sugaya, K Ohata, Y Natsuki, ...
Clinical and Experimental Nephrology, 1-11, 2021
202021
Urinary level of liver-type fatty acid binding protein reflects the degree of tubulointerstitial damage in polycystic kidney disease
S Watanabe, D Ichikawa, T Sugaya, K Ohata, K Inoue, S Hoshino, ...
Kidney and Blood Pressure Research 43 (6), 1716-1729, 2018
162018
Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression
K Ohata, A Kamijo-Ikemori, T Sugaya, C Hibi, T Nakamura, T Murase, ...
European Journal of Pharmacology 815, 88-97, 2017
162017
The possibility of urinary liver-type fatty acid-binding protein as a biomarker of renal hypoxia in spontaneously diabetic torii fatty rats
J Tanabe, Y Ogura, M Nakabayashi, Y Nagai, S Watanabe, T Sugaya, ...
Kidney and Blood Pressure Research 44 (6), 1476-1492, 2019
142019
Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats
S Yamada, Y Ogura, K Inoue, J Tanabe, T Sugaya, K Ohata, Y Nagai, ...
Molecular and Cellular Endocrinology 539, 111472, 2022
102022
Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice
K Kosaki, T Sugaya, K Ohata, J Tanabe, S Hoshino, K Inoue, K Kimura, ...
Hypertension Research 42 (10), 1518-1527, 2019
102019
Temporal changes in urinary excretion of liver-type fatty acid binding protein (L-FABP) in acute kidney injury model of domestic cats: a preliminary study
M Katayama, T Miyazaki, K Ohata, T Oikawa, J Kamiie, T Sugaya, ...
Journal of Veterinary Medical Science 81 (12), 1868-1872, 2019
102019
Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease
M Katayama, K Ohata, T Miyazaki, R Katayama, N Wakamatsu, M Ohno, ...
Journal of veterinary internal medicine 34 (2), 761-769, 2020
82020
Relationship between urinary liver-type fatty acid-binding protein (L-FABP) and sarcopenia in spontaneously diabetic torii fatty rats
J Tanabe, Y Ogura, K Kosaki, Y Nagai, T Sugaya, K Ohata, S Watanabe, ...
Journal of diabetes research 2020, 2020
82020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20